Types

There are two distinct forms of graft-versus-host disease (GvHD), acute and chronic.

Steroid-refractory GvHD

Corticosteroids are often the first treatment used for acute or chronic graft-versus-host disease. Healthcare professionals may further describe graft-versus-host disease based on how well the condition responds to corticosteroid therapy.

What is graft-versus-host disease?

Graft-versus-host disease (GvHD) is a complication that can occur following an allogeneic hematopoietic stem cell transplantation.

How do you include a patient’s perspective when selecting treatment and monitoring response in GvHD?

Know GvHD was pleased to speak to Mohamad Mohty, Hôpital Saint-Antoine and Sorbonne University, Paris, FR. We asked, How do you incorporate the patient’s perspective when selecting treatments and monitoring responses in GvHD?

What does responding to treatment mean to you, and does this differ from a physician’s perspective?

Know GvHD was pleased to speak to Joanne Stobart, UK. We asked, What does responding to treatment mean to you, and have you ever felt that this differs from a physician’s perspective?

How can patients become involved in clinical trials, and why is it important to capture their experience?

Know GvHD was pleased to speak to Mohamad Mohty, Hôpital Saint-Antoine and Sorbonne University, Paris, FR. We asked, How can patients become involved in clinical trials, and why is it important to capture their experience?

What is the prognosis after ECP?

An overview of the prognosis for patients with GvHD after undergoing ECP and how organs may respond differently.

How long is the process of ECP?

This graphic provides an explanation of ECP, including how long the process can take and when a response may be seen.

What are the side effects of ECP?

A summary of the common side effects of ECP, which can include nausea, light sensitivity, and dizziness.